Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech Cable One Inc CABO Q1 2026 Earnings EPS Surpasses Estimates Amid Unreported Revenue OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline JD Q1 2026 Earnings EPS Misses Estimates Shares Decline on Weak Profitability 111 Inc Q3 2024 Earnings Narrowed Loss per ADS Supports Positive Stock Movement ACLS Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher